LEGAL AND ETHICAL ISSUES IN PSYCHEDELIC PSYCHOTHERAPY
One Day Workshop – SAT, JUNE 1, 2019 – 9am – 5pm – Victoria, BC
Psychedelic medicine offers revolutionary and promising new treatments for some of the great mental health challenges of our age: anxiety, depression, addiction and PTSD. Therapists can expect that increasing numbers of clients will ask about psychedelic psychotherapy as an option, and many clinicians who follow current research will want to advocate for access to psychedelic psychotherapy for their clients.
This situation raises some important legal and ethical questions for both service providers and consumers:
- To what extent can therapists legally and ethically encourage client interest in using a psychedelic for therapeutic reasons?
- What specific messages can therapists rightfully give clients regarding medical use of psychedelics without our going over legal or ethical red lines?
- Are there circumstances under which the practice of psychedelic psychotherapy could be considered legally defensible?
- Are there circumstances in which it is ethically defensible for a clinician to contravene Canadian drug law?)
- How can therapists remain accountable and work within ethical boundaries?
- Do therapists have an ethical responsibility to somehow professionally intervene when they have reason to believe another health worker has violated ethical boundaries?
- What recourse might consumers consider if they feel that a therapist/shaman/health professional has acted unethically toward them?
Let’s grapple with these questions and more in large and small group discussions! Let’s create a community conversation about how to move psychedelic medicine forward in an ethically grounded and professionally accountable manner.
Bring your ideas, questions, challenges and concerns! Bring your critical thinking. Let’s hear your voice!
Maximum participants: 24
SOLD OUT. Registration is now closed.
Bruce Tobin, Ph.D., Registered Clinical Counsellor, has been a psychotherapist in private practice in Victoria for the past 30 years. While strongly committed to practicing within the legal and ethical boundaries of his profession, he would like to see the promising benefits of psychedelic medicine made available now to clients in dire need when other treatments are not effective. Bruce is currently working on a legal initiative to provide a path to legitimate clinical use of psychedelics for certain patients. It challenges current Canadian law using arguments based on the Canadian Charter of Rights and Freedoms that were accepted by the Supreme Court in their ruling for the use of medical cannabis.
Marcia McMillan, Ph.D., Registered Psychologist (BC#1182), graduated from McGill University in 1987 with a doctorate in Clinical Psychology. She worked as a private practice clinician for 19 years with a specialization in PTSD. In recent years her interest in psychedelic psychotherapy has been sparked by the exciting research being published. She sees great promise in employing psychedelics with treatment-resistant clinical disorders and end-of-life anxiety. However, she believes that an unshakeable foundation of best practices must be laid for this field to transition to a viable legal choice. Pristine ethical practice represents a large cornerstone in this foundation.